Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

Pouillon Lieven; Bossuyt Peter; Peyrin-Biroulet Laurent

首页> 外文期刊>Expert opinion on biological therapy >Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

【24h】

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

机译：抗TNF治疗炎症性肠病的考虑，挑战和未来

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Crohn's disease (CD) and ulcerative colitis (UC) are chronic disabling conditions. Monoclonal antibody therapy directed against tumor necrosis factor-alpha (anti-TNF) has revolutionized the care of patients with inflammatory bowel disease (IBD).

机译：简介：克罗恩病（CD）和溃疡性结肠炎（UC）是慢性致残疾病。针对肿瘤坏死因子-α（anti-TNF）的单克隆抗体疗法彻底改变了炎症性肠病（IBD）患者的护理方式。

著录项

来源
《Expert opinion on biological therapy》 |2016年第10期|共14页
作者
Pouillon Lieven; Bossuyt Peter; Peyrin-Biroulet Laurent;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Adalimumab; anti-TNF; biosimilar; combination therapy; certolizumab pegol; Crohn's disease; golimumab; inflammatory bowel disease; infliximab; personalized medicine; pharmacogenomics; tailored therapy; therapeutic drug monitoring; TNF antagonists; ulcerative colitis;

机译：阿达木单抗;抗TNF;生物仿制药;联合治疗;赛妥珠单抗聚乙二醇;克罗恩病;戈利木单抗;炎症性肠病;英夫利昔单抗;个性化药物;药物基因组学;量身定制的治疗;治疗药物监测;TNF拮抗剂;溃疡性结肠炎;

相似文献

外文文献
中文文献
专利

1. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease [J] . Pouillon Lieven, Bossuyt Peter, Peyrin-Biroulet Laurent Expert opinion on biological therapy . 2016,第10期

机译：抗TNF治疗炎症性肠病的考虑，挑战和未来
2. A CASE SERIES OF LISTERIA MONOCYTOGENES INFECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ANTI-TNF alpha THERAPY [J] . Gray J. A., Allen P. B., Diong K., Gut: Journal of the British Society of Gastroenterology . 2013,第Suppla2期

机译：TNF-α治疗的炎症性肠病患者一系列单核细胞增多性单胞菌感染
3. Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease [J] . Peng Jiang Chen, Shen Jun, Ran Zhi Hua Journal of digestive diseases . 2014,第11期

机译：未来的新型药物：炎症性肠病以外的抗TNF药物治疗
4. State-of-the-Art Lecture: Future therapies in inflammatory bowel diseases [C] . J. SCHOLMERIC Falk Symposium . 2008

机译：最先进的讲座：炎症性肠病的未来疗法
5. Oxidation Status as a Predictor of Disease Activity and Response to Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Ajithkumar, Aravindh K. 2020

机译：氧化地位作为疾病活动的预测因素，对炎症性肠病儿科患者的疗法响应
6. Implementable Strategies and Exploratory Considerations to Reduce Costs Associated with Anti-TNF Therapy in Inflammatory Bowel Disease [O] . KT Park, Wallace V. Crandall, Jacqueline Fridge, -1

机译：降低与炎症性肠病抗TNF治疗相关的费用的可行策略和探索性考虑
7. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study [O] . Annick Moens, C. Janneke van der Woude, Mette Julsgaard, 2019

机译：炎症性肠病患者妊娠晚期治疗，抗TNF或常规治疗：欧洲设想研究的结果

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

摘要

著录项

相似文献

相关主题

期刊订阅